Ignite Creation Date:
2025-12-24 @ 4:11 PM
Ignite Modification Date:
2025-12-30 @ 4:27 AM
Study NCT ID:
NCT00023166
Status:
TERMINATED
Last Update Posted:
2005-06-24
First Post:
2001-08-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas
Sponsor:
Enzon Pharmaceuticals, Inc.
Organization:
Study Overview
Official Title:
Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors and Lymphomas
Status:
TERMINATED
Status Verified Date:
2004-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Studies of PEG-paclitaxel have been terminated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: